Bhringraj for Hair Fall: The Ayurvedic Herb That Clinical Science Is Finally Catching Up With

Bhringraj — known in Ayurvedic medicine as Kesharaja, the "King of Hair" — has been part of Indian hair care for over 3,000 years. It appears in the Charaka Samhita, one of the foundational texts of Ayurvedic medicine, as a primary remedy for hair fall, premature greying, and scalp conditions. For most of that history, its use was based on tradition and observational efficacy — passed from practitioner to practitioner without the controlled clinical validation that modern medicine demands.

That is beginning to change. A 2025 peer-reviewed clinical trial published in the Journal of Ayurveda and Integrated Medical Sciences evaluated standardised Bhringraj extract in adults with documented hair fall over 24 weeks — the kind of rigorous, placebo-monitored evidence that places traditional herbs alongside modern clinical actives in the conversation about evidence-based hair care.

The results are worth understanding in detail. So is the mechanism — because Bhringraj does not work through a single pathway, and that multi-mechanism action is precisely what makes it relevant alongside clinical actives like Procapil and Anagain.

What Bhringraj Actually Contains

Bhringraj's therapeutic activity comes from several key bioactive compounds:

Wedelolactone — a coumestan compound with documented anti-inflammatory, hepatoprotective, and follicle-stimulating properties. Research published in the International Journal of Molecular Medicine showed that exogenous stimulation with Eclipta alba extracts promotes hair matrix keratinocyte proliferation — the cell division responsible for new hair shaft production.

Ecliptine — an alkaloid specific to Eclipta species with documented inhibitory effects on 5-alpha reductase, the enzyme that converts testosterone to DHT. This is the same enzyme pathway targeted by pharmaceutical DHT blockers like finasteride — Bhringraj acts on it through a naturally occurring compound.

Luteolin — a flavonoid with powerful antioxidant and anti-inflammatory action. Oxidative stress at the follicle level is a documented driver of premature hair fall, and luteolin directly scavenges the reactive oxygen species that damage follicle cells.

Wedelolactone and demethylwedelolactone — additionally studied for their ability to downregulate TGF-β1 — a growth factor that promotes premature transition from anagen to catagen (the shrinking phase). Reducing TGF-β1 activity means more follicles stay in the growth phase longer.

Taken together, Bhringraj acts through at least four separate mechanisms: DHT inhibition, follicle cell proliferation stimulation, antioxidant protection, and growth phase extension. It is not a single-pathway herb — it is a multi-mechanism botanical that addresses several of the same pathways as modern clinical actives simultaneously.

What the 2025 Clinical Trial Found

The 24-week prospective trial published in the Journal of Ayurveda and Integrated Medical Sciences enrolled 54 adults aged 18–55 with documented increased hair shedding. Participants received standardised oral Eclipta alba extract tablets. Outcomes were measured using the validated 60-second comb test, weekly diary hair counts, and Patient Global Impression of Change.

50 participants completed the full study. Results showed:

•     Statistically significant reduction in 60-second comb test hair counts at both Week 12 and Week 24, compared to baseline

•     Statistically significant reduction in weekly diary hair counts at Week 24

•     Strong positive Patient Global Impression of Change scores at Week 24

•     No adverse effects on vital signs or hepatic function across the 24-week period

This is the first rigorously conducted prospective clinical trial of standardised Bhringraj in an Indian adult population with documented hair fall — and it confirms what Ayurvedic practitioners have observed for centuries.

The Animal Study Comparison with Minoxidil

Earlier experimental research provided the mechanistic data that the clinical trial builds on. Studies in animal models demonstrated that Eclipta alba-treated groups showed:

•     Hair follicle density and anagen phase promotion comparable to Minoxidil 2% treatment groups

•     Significant reduction in the catagen-to-anagen transition time

•     Proliferation of hair matrix keratinocytes in histological examination

This comparison with Minoxidil is significant not because Bhringraj replaces Minoxidil — it does not have the same potency for androgenetic alopecia — but because it validates the follicle-level mechanism of action through a pathway that is well-understood in modern trichology.

How Bhringraj Fits With Modern Clinical Actives

Bhringraj does not compete with ingredients like Procapil or Anagain — it complements them. Where Procapil focuses on follicle anchoring and microcirculation, and Anagain on growth phase signalling, Bhringraj contributes antioxidant protection and DHT inhibition through its own distinct chemical compounds. Together they address the follicle environment from multiple angles simultaneously.

This is the philosophy behind the Cerise Naturals formulation approach: combining Ayurvedic-derived actives with clinical cosmetic ingredients because each operates on a different mechanism, and addressing multiple mechanisms simultaneously produces more comprehensive results than any single ingredient.

Bhringraj in the Cerise Anti Hair Fall Shampoo

The Cerise Naturals Anti Hair Fall Shampoo contains Bhringraj alongside Amla, Procapil, Keratin, and Biotin. Formulated sulphate-free to preserve scalp barrier integrity while delivering these actives to the scalp during each wash.

Amla (Indian gooseberry) complements Bhringraj directly — it provides Vitamin C and ellagitannins that further enhance antioxidant protection at the follicle, reduce scalp inflammation, and provide mild antifungal support against Malassezia-driven dandruff.

Procapil adds the structural follicle anchoring and microcirculation improvement that Bhringraj's mechanism does not specifically address — making the combination more complete than either ingredient alone.

For maximum benefit, pair the Anti Hair Fall Shampoo with the Cerise Naturals Anti Hair Fall Serum — which delivers Procapil 2%, Anagain 2%, Biotin 1%, Saw Palmetto 2%, and Keratin 2% in a leave-on application that maintains scalp-level ingredient exposure between washes.

The Broader Point About Ayurvedic Evidence

Bhringraj is an example of something increasingly common in hair care research: Ayurvedic ingredients with long observational track records now being subjected to the rigorous trial designs that generate clinical evidence. The results are frequently not surprising to practitioners who have worked with these herbs for decades — but they matter, because clinical evidence is what allows intelligent consumers to make informed decisions rather than choosing between tradition and science as if they were mutually exclusive.

They are not. Bhringraj has Ayurvedic history and a 24-week clinical trial. Cerise Naturals was founded on precisely this combination.